Diazoxide Quantitative, Serum or Plasma
Also known as: DIAZOXID
Use
The Diazoxide Quantitative test measures the concentration of diazoxide in serum or plasma. Diazoxide is a medication used to manage hypoglycemia caused by excessive insulin secretion. This test is crucial for monitoring the drug level in patients receiving diazoxide treatment to ensure therapeutic levels are maintained without reaching toxic concentrations. Accurate measurement of diazoxide levels helps in adjusting doses to achieve optimal therapeutic outcomes while minimizing potential side effects.
Special Instructions
Not provided.
Limitations
The test's performance characteristics have not been cleared or approved by the US Food and Drug Administration. Results may vary depending on the laboratory performing the test. Precision in specimen handling and preparation is critical as the test requires specific conditions for stability and storage. Separator tubes are not acceptable for specimen collection, which can potentially affect the accuracy of results.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Diazoxide
Analyte
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer to an ARUP Standard Transport Tube.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 weeks |
| Refrigerated | 1 month |
| Frozen | 2 years |
Other tests from different labs that may be relevant